- BNF:
- Not listed
- Status:
- Red
- Decision Date:
- August 2018
Comments
RED1,2,3,8: NICE TA528 - maintenance treatment of relapsed, platinum-sensitive ovarian, fallopian tube and peritoneal cancer.
RED1,2,3,8: NICE TA673- maintenance treatment of
advanced ovarian, fallopian tube and peritoneal cancer after response to
first-line platinum-based chemotherapy. NHSE commissioned (Decision date - March 2021)
RED1,2,3,8: NICE TA784- maintenance treatment of relapsed, platinum-sensitive ovarian, fallopian tube and peritoneal cancer. (Decision date - May 2022)
NHSE commissioned
Red Drug Classifications
- 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
- 2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care
- 3: Requiring long term on-going monitoring of toxicity by a specialist (either because of difficulty in recognising side effects or high cost of investigations to identify toxicity)
- 8. NHS England commissioned – to be used in line with NHSE commissioning intentions
search again